Flow Cytometry Applications in Hematologic Malignancies: Current Advances and Clinical Implications for Laboratory Medicine

Authors

  • MAMDOOH FAHAD ALHARBI Medical Laboratories specialist, Prince Sultan military medical city, Riyadh
  • Saleh Sulaiman Saleh Alrufayyiq Medical Laboratory Technician, Prince Sultan military medical city, Riyadh
  • Mudawi Saleh Awadh Alwadai Medical Laboratories specialist, Prince Sultan military medical city, Riyadh
  • Zaher Mohammad Ahmad AL Bargi Medical Laboratories specialist, Prince Sultan military medical city, Riyadh
  • Adel dhafer mubarak alshuflut Medical laboratory specialist, Prince Sultan military medical city, Riyadh
  • Ali Abdullah Ali Alghathami Medical Laboratories specialist, Prince Sultan military medical city, Riyadh

DOI:

https://doi.org/10.63332/joph.v5i1.3145

Keywords:

flow cytometry, hematologic malignancies, minimal residual disease, immunophenotyping, leukemia, lymphoma, multiparameter analysis, spectral flow cytometry, clinical laboratory, quality assurance

Abstract

Flow cytometry has revolutionized the diagnosis, classification, and monitoring of hematologic malignancies, emerging as an indispensable tool in modern clinical laboratories. This comprehensive review examines the current applications of multiparameter flow cytometry (MFC) in the diagnosis and management of leukemias, lymphomas, and plasma cell disorders. The study explores the technical principles underlying flow cytometric analysis, including antibody panel design, gating strategies, and data interpretation protocols. Recent technological advances, including spectral flow cytometry and artificial intelligence integration, have expanded diagnostic capabilities and improved analytical precision. Minimal residual disease (MRD) monitoring represents a critical application, providing prognostic information and treatment guidance across various hematologic malignancies. Multiparameter flow cytometry (MPF) is an essential component of the diagnostic workup of hematologic malignancies, with standardized protocols ensuring reproducible results across laboratories. Quality assurance measures, including appropriate controls, standardization protocols, and proficiency testing, are essential for maintaining analytical excellence. This review addresses current challenges in flow cytometric analysis, including specimen handling, data interpretation complexity, and the need for specialized expertise. Emerging applications in germline predisposition screening and immunophenotypic monitoring of novel therapeutic interventions demonstrate the evolving role of flow cytometry in hematologic oncology. The integration of flow cytometry with complementary techniques such as cytogenetics and molecular diagnostics enhances diagnostic accuracy and provides comprehensive patient assessment. Future directions include expanded spectral capabilities, enhanced automation, and improved artificial intelligence applications for result interpretation and quality control.

Downloads

Published

2025-01-05

How to Cite

ALHARBI, M. F., Alrufayyiq, S. S. S., Alwadai, M. S. A., AL Bargi, Z. M. A., alshuflut, A. dhafer mubarak, & Alghathami, A. A. A. (2025). Flow Cytometry Applications in Hematologic Malignancies: Current Advances and Clinical Implications for Laboratory Medicine. Journal of Posthumanism, 5(1), 1700–1723 . https://doi.org/10.63332/joph.v5i1.3145

Issue

Section

Articles